Cargando…

Management of sarcoidosis in clinical practice

Sarcoidosis is a systemic disease of unknown cause with very diverse presentation, outcome, severity and need for treatments. While some presentations may be very typical, for many patients, the presentation is nonspecific, with shared associations with other diseases at times being by far more freq...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeny, Florence, Bouvry, Diane, Freynet, Olivia, Soussan, Michael, Brauner, Michel, Planes, Carole, Nunes, Hilario, Valeyre, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487239/
https://www.ncbi.nlm.nih.gov/pubmed/27246591
http://dx.doi.org/10.1183/16000617.0013-2016
_version_ 1784792448066650112
author Jeny, Florence
Bouvry, Diane
Freynet, Olivia
Soussan, Michael
Brauner, Michel
Planes, Carole
Nunes, Hilario
Valeyre, Dominique
author_facet Jeny, Florence
Bouvry, Diane
Freynet, Olivia
Soussan, Michael
Brauner, Michel
Planes, Carole
Nunes, Hilario
Valeyre, Dominique
author_sort Jeny, Florence
collection PubMed
description Sarcoidosis is a systemic disease of unknown cause with very diverse presentation, outcome, severity and need for treatments. While some presentations may be very typical, for many patients, the presentation is nonspecific, with shared associations with other diseases at times being by far more frequent or misleading, which can be a cause of significant delay and often several consultations before a diagnosis of sarcoidosis can be confirmed. This is particularly the case when pulmonary manifestations are in the forefront. The diagnosis relies on three well-known criteria. In clinical practice, these criteria are not easily implemented, particularly by physicians without expertise in sarcoidosis, which can lead to a risk of either under- or over-diagnosis. Qualifying the presentation according to sarcoidosis diagnosis is essential. However, it is often not easy to classify the presentation as typical versus compatible or compatible versus inconsistent. Further investigations are needed before any other hypothesis is to be considered. It is important to detect events and to determine whether or not they are indicative of a flare of sarcoidosis. Eventually, treatment needs to be related to the correct indications. The evaluation of the efficacy and safety of treatments is crucial. To address such issues, we present five emblematic cases that illustrate this.
format Online
Article
Text
id pubmed-9487239
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-94872392022-11-14 Management of sarcoidosis in clinical practice Jeny, Florence Bouvry, Diane Freynet, Olivia Soussan, Michael Brauner, Michel Planes, Carole Nunes, Hilario Valeyre, Dominique Eur Respir Rev Frontiers in Clinical Practice Sarcoidosis is a systemic disease of unknown cause with very diverse presentation, outcome, severity and need for treatments. While some presentations may be very typical, for many patients, the presentation is nonspecific, with shared associations with other diseases at times being by far more frequent or misleading, which can be a cause of significant delay and often several consultations before a diagnosis of sarcoidosis can be confirmed. This is particularly the case when pulmonary manifestations are in the forefront. The diagnosis relies on three well-known criteria. In clinical practice, these criteria are not easily implemented, particularly by physicians without expertise in sarcoidosis, which can lead to a risk of either under- or over-diagnosis. Qualifying the presentation according to sarcoidosis diagnosis is essential. However, it is often not easy to classify the presentation as typical versus compatible or compatible versus inconsistent. Further investigations are needed before any other hypothesis is to be considered. It is important to detect events and to determine whether or not they are indicative of a flare of sarcoidosis. Eventually, treatment needs to be related to the correct indications. The evaluation of the efficacy and safety of treatments is crucial. To address such issues, we present five emblematic cases that illustrate this. European Respiratory Society 2016-06 /pmc/articles/PMC9487239/ /pubmed/27246591 http://dx.doi.org/10.1183/16000617.0013-2016 Text en Copyright ©ERS 2016. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Frontiers in Clinical Practice
Jeny, Florence
Bouvry, Diane
Freynet, Olivia
Soussan, Michael
Brauner, Michel
Planes, Carole
Nunes, Hilario
Valeyre, Dominique
Management of sarcoidosis in clinical practice
title Management of sarcoidosis in clinical practice
title_full Management of sarcoidosis in clinical practice
title_fullStr Management of sarcoidosis in clinical practice
title_full_unstemmed Management of sarcoidosis in clinical practice
title_short Management of sarcoidosis in clinical practice
title_sort management of sarcoidosis in clinical practice
topic Frontiers in Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487239/
https://www.ncbi.nlm.nih.gov/pubmed/27246591
http://dx.doi.org/10.1183/16000617.0013-2016
work_keys_str_mv AT jenyflorence managementofsarcoidosisinclinicalpractice
AT bouvrydiane managementofsarcoidosisinclinicalpractice
AT freynetolivia managementofsarcoidosisinclinicalpractice
AT soussanmichael managementofsarcoidosisinclinicalpractice
AT braunermichel managementofsarcoidosisinclinicalpractice
AT planescarole managementofsarcoidosisinclinicalpractice
AT nuneshilario managementofsarcoidosisinclinicalpractice
AT valeyredominique managementofsarcoidosisinclinicalpractice